Locations:
Search IconSearch
January 25, 2019/Cancer

From Pharmacist to Dermatologist: Never Be Afraid to Reinvent Yourself

A Q&A with Allison Vidimos, RPh, MD

650x450_Vidimos

Allison T. Vidimos, RPh, MD, Chair of the Department of Dermatology, specializes in skin cancer, micrographic surgery (Mohs) and laser surgery, and has been among the “Best Doctors in America” every year since 1998. Dr. Vidiomos is Staff Physician in the Section of Micrographic Surgery (Mohs) and Oncology in the Department of Dermatology, and Professor at Cleveland Clinic Lerner College of Medicine. She is also the Program Director of the Procedural Dermatology Fellowship. In this Q&A, Dr. Vidimos shares her journey from pharmacist to dermatologist, and how she keeps her practice stimulating and meaningful.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Halfway through pharmacy school at Purdue University, Allison Vidimos, RPh, MD, participated in hospital rounds with a physician team. Seeing what they were doing, she realized she wanted to do the same.

“I made the decision to finish pharmacy school, took the board exam, and worked two pharmacy jobs while in medical school,” says our Department Chair of Dermatology and an Expert Physician Consultant to the Compounding Committee of the United States Pharmacopoeia. “I do not regret that decision. Pharmacy school was excellent preparation for me to go into medicine.”

She chose her specialty for the variation it offered. “In dermatology, we’re seeing patients from newborn babies to 104 year olds,” Dr. Vidimos says. “As a dermatologist and a dermatologic surgeon, I am treating many different conditions, performing surgical procedures and working with gifted colleagues. I find my practice intellectually stimulating and rewarding.”

Why do you choose to practice at Cleveland Clinic?
I came for my residency in dermatology — one of the best training programs in the country — and stayed on as staff after a two-year Mohs fellowship because I truly enjoy and appreciate my colleagues and the variety of patients we see. The teamwork model helps us to deliver the best care. Our multidisciplinary non-melanoma and melanoma tumor boards are great examples of teamwork. I truly enjoy teaching medical students, residents and fellows and having the opportunity to do clinical research.

Do you have a time-saving tip to share?
The Epic Haiku app on my iPhone has helped me to be more efficient. Because I can access their home and cell numbers on the app, I use it to call many of my skin cancer surgery patients the night of their surgeries to make sure their pain is controlled and that there are no problems with bleeding. I also use it to check biopsy results when away from a computer.

In 2005 you were named the first female department chair at Cleveland Clinic. Any advice on taking a leadership position?
I was hesitant to throw my hat in the ring for the chair position. My girls, Kristen and Katherine, were 10 and 12 years old and my husband, Todd Stultz, DDS, MD, had just recently finished his radiology residency and neuroradiology fellowship. My family, as well as the former Chief of Staff Rob Kay, MD, were very supportive and encouraging.

Advertisement

I had some great mentors, such as Rich Lang, MD, who was the Chairman of Internal Medicine at that time. I took advantage of the leadership offerings at Cleveland Clinic as well as courses offered by our Women’s Professional Staff Association and the American Academy of Dermatology. The coaching, teaching and leadership experiences at Cleveland Clinic have facilitated other opportunities as well. I was elected the first woman president of the American College of Mohs Surgery in 2017-18 for the 50th anniversary meeting, and was appointed as a Director for the American Board of Dermatology in 2018.

What advice you would give to your 20-year-old self?
Don’t ever be afraid to reinvent yourself. My husband Todd and I affectionately call ourselves “retreads.” I switched from working as a pharmacist to a dermatologist. My husband was a dentist when we got married, and at age 32 he decided he wanted to go to medical school. He is able to use his dental background in maxillofacial imaging cases.

Giving back is important to you. What unique ways have you been able to accomplish this throughout your career?
I have been fortunate to participate in 11 medical mission trips to Honduras. Cleveland Clinic cardiologist Russ Raymond, DO, gave me this amazing opportunity 12 years ago. Our team has seen up to 3,2000 patients in six days with eight to nine physicians. It’s a quick pace (no EMR!), but the patients are so in need and so grateful to receive medical care. I have taken some of my residents and my daughters on these yearly trips, and it has been personally and professionally gratifying for all of us.

Advertisement

Related Articles

Dr. Holly Pederson
July 25, 2024/Cancer/Research
Evaluating Risk Scores for Triple-Negative Breast Cancer in Black Women (Podcast)

Polygenic risk score could help predict who will develop this aggressive breast cancer

Reviewing dental scans
July 8, 2024/Cancer
A Call for More Interdisciplinary and Preventive Care in New Osteoradionecrosis Guidelines

New guidelines offer insight into emerging therapies, dental issues and more

Dr. AlHilli
July 3, 2024/Cancer/Patient Support
Prehabilitation Program Aims to Improve Outcomes for Older Patients with Ovarian or Pancreatic Cancer

Clinical trial to assess the value of nutritional, physical therapy and social supports prior to preoperative chemotherapy

Dr. Nahleh
June 26, 2024/Cancer/Patient Support
Systemic Treatment a Major Factor Impacting Survival of Patients with Breast Cancer with Brain Metastasis

Research demonstrates improved overall survival for patients receiving comprehensive treatment for breast cancer in addition to radiation or surgical intervention for brain cancer

Image showing Dr. Gupta
June 20, 2024/Cancer/Research
Trailblazing Urothelial Cancer Treatments (Podcast)

Platinum-eligible phase 3 trial of enfortumab vedotin and pembrolizumab yields ‘unprecedented data’

Dr. Grobmyer and team
June 14, 2024/Cancer/Innovations
Fatima bint Mubarak Center Addresses Inequities in Cancer Care

Cleveland Clinic Cancer Institute brings multidisciplinary care, precision oncology and clinical research to the United Arab Emirates

Lung cancer cells
June 5, 2024/Cancer/Research
Impact of Tumor Burden on Survival for Patients with EGFR-Mutant NSCLC Treated with Osimertinib

Extent of baseline burden impacts progression-free and overall survival

cancer cells
June 4, 2024/Cancer/Research
Researchers Identify Tumor Microbiome Differences in Early- vs. Average-Onset Pancreatic Adenocarcinoma

Further study warranted to better understand the clinical implications of these findings

Ad